Table 3 The outcomes of the participants
Serial No | Group A (N = 19) | Group B (N = 25) | |
|---|---|---|---|
1 | Age (years) | 52.68 ± 18.31 | 52.76 ± 11.67 |
2 | Gender | % | |
Male | 68.4 | 88 | |
Female | 31.6 | 12 | |
3 | Hospitalization period (day) | 23.68 ± 7.74 | 33.56 ± 19.47 |
4 | Clinical healing period (month) | 2.84 ± 0.47 | 3.20 ± 0.43 |
5 | Pre-operation VAS score | 7.63 ± 1.26 | 7.20 ± 1.12 |
6 | Post operation day 3 VAS score | 3.21 ± 0.71 | 3.28 ± 0.68 |
7 | Post operation 1-month VAS score | 1.16 ± 0.83 | 1.32 ± 1.20 |
8 | Gustilo-Anderson classification | % | |
Type 1 | 15.8 | 12 | |
Type 2 | 47.4 | 40 | |
Type 3 A | 21.1 | 20 | |
Type 3 B | 10.5 | 24 | |
Type 3 C | 5.3 | 4 | |
9 | Re-operation | % | |
Yes | 26.3 | 48 | |
No | 73.7 | 52 | |
10 | Johner-Wrush score | % | |
Excellent | 84.2 | 56 | |
Good | 15.5 | 44 | |
11 | Complication | % | |
Had complications | 15.8 | 48 | |
No complication | 84.2 | 52 | |
12 | Average estimated cost (¥) | 26,619.26 ± 9,602.352 | 39,095.64 ± 20,070.077 |